Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

enVVeno Medical Corp (NVNO)

$10.39 +2.77% NASDAQ: NVNO · 15-min delayed
  • IRVINE, California
  • Public · NASDAQ: NVNO
  • 33 employees
$6.8MMarket cap
$31.2KRevenue · FY2019
-$19.5MNet income
33Employees
NVNONASDAQ
2018IPO

About enVVeno Medical Corp

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2019
$31.2K
Net income
-$19.5M
Total assets
$29.6M
Market cap
$6.8M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Operating income
-$20.9M
Net income
-$19.5M
EPS (basic)
$-33.06
EPS (diluted)
$-33.06

Balance sheet

Total assets
$29.6M
Current assets
$28.8M
Total liabilities
$2.4M
Current liabilities
$2.1M
Shareholders’ equity
$27.1M

Cash flow

Operating cash flow
-$15.6M
Investing cash flow
$15.9M
Financing cash flow
$1.0M
Net cash flow
$1.3M

Statements via Polygon.io (SEC filings)

NASDAQ: NVNO
$10.39 +2.77%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$8.67 $183.75

52-week range

Market cap
$6.8M
EPS (diluted)
$-33.06
Shares outstanding
656.1K
Open
Day range
Prev close
Volume
IPO date
May 31, 2018

enVVeno Medical Corp (NVNO) Stock Price

  • Reported a net loss of $19.5M in FY2019.
  • Trading 94% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review enVVeno Medical Corp.

Write a review
Newsroom

News about enVVeno Medical Corp

News & sentiment via Polygon.io

FAQ

enVVeno Medical Corp: frequently asked questions

Is enVVeno Medical Corp an American company?

enVVeno Medical Corp is a US-based company headquartered in Irvine, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is enVVeno Medical Corp headquartered?

enVVeno Medical Corp is headquartered in Irvine, California, United States.

Is enVVeno Medical Corp publicly traded?

Yes — enVVeno Medical Corp is a publicly traded company. Its stock trades under the ticker symbol NVNO on the NASDAQ.

What does enVVeno Medical Corp do?

enVVeno Medical Corp is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →